Fermenta Biotech Limited

BSE: 506414 NSE: FERMENTA
Fermenta Biotech Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN L99999MH1951PLC008485 Incorporated 01 May 1951 ROC Mumbai HQ Thane, Maharashtra, India
Active Listed - NSE: FERMENTA · BSE: 506414 Public Limited Company pharma
Data last updated
Market Cap
₹1,349 Cr
FERMENTA · NSE
Share Price
₹450.60
-1.69% today
Revenue
₹525 Cr
FY 2025-26 · +11.9% YoY
EBITDA
₹101 Cr
Margin 19.2%
Net Profit
₹62.91 Cr
FY 2025-26 · -22.4% YoY
P/E (TTM)
25.0x
P/B 3.4x
ROE
18.3%
ROCE 20.7%
Debt / Equity
0.30
Interest cover 16.0x

About Fermenta Biotech Limited

Data last updated:

Fermenta Biotech Limited is a public limited company based in Thane, Maharashtra, India, a subsidiary of Dvk Investments Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 01 May 1951 and has been in existence for over 75 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L99999MH1951PLC008485. Its GSTIN is 27AAACD0525E1Z9 (Maharashtra). The company holds 14 GST registrations, of which 13 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 506414 and NSE: FERMENTA.

The company has an authorised share capital of ₹31.83 Cr and a paid-up capital of ₹14.72 Cr. It was formerly known as International Franchises Private Limited and International Franchises Limited. It is led by directors including Prashant Prabhakar Nagre (Managing Director) and Anupama Datla Desai (Whole-Time Director).

Its last annual general meeting (AGM) was held on 12 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at A – 1501 Thane One Dil Complex Ghodbunder Road Majiwade Thane (West) 400 610 Maharash, Tra India, Maharashtra, India – 400610.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹525.43 Cr, a growth of 11.9% compared to the previous year. For the same year it recorded a net profit of ₹62.91 Cr (net margin 12%) and EBITDA of ₹100.96 Cr (EBITDA margin 19.2%). The net worth stands at ₹406.22 Cr (up 12% YoY). Total assets are valued at ₹541.41 Cr (up 8.7% YoY).

The company has about 327 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

As per MCA filings, the company has open charges of ₹294.16 Cr and satisfied charges of ₹351.46 Cr on record. Court records list 28 cases involving the company, including 15 filed by the company and 13 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fermentabiotech.com.

Company details

CIN L99999MH1951PLC008485
Registration Number 008485
Incorporation Date 01 May 1951
ROC Mumbai
Listing Status Listed - Listed on NSE (FERMENTA); Listed on BSE (506414)
Company Status Active
Date of Last AGM 12 August 2025
Date of Balance Sheet 31 March 2026
Parent Company Dvk Investments Private Limited
Compliance Status Active Compliant

Name history

Fermenta Biotech has undergone 3 name changes throughout its history. The company was previously known as International Franchises Private Limited, International Franchises Limited, and Dil Limited. The current legal name is Fermenta Biotech Limited.

Company NameStatus
Fermenta Biotech LimitedCurrent
International Franchises Private LimitedPrevious
International Franchises LimitedPrevious
Dil LimitedPrevious
Key People
Prashant Prabhakar Nagre Managing Director Anupama Datla Desai Whole-Time Director Satish Varma Azad Nadimpally Whole-Time Director

Contact details

Fermenta Biotech Limited's registered office is in Thane, Maharashtra. Its website is fermentabiotech.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    fermentabiotech.com
  • Social Media
  • Registered Address
    A – 1501 Thane One Dil Complex Ghodbunder Road Majiwade Thane (West) 400 610 Maharash, Tra India, Maharashtra, India – 400610
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Fermenta Biotech Limited, buy the company report.

Comprehensive company report
Fermenta Biotech Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Fermenta Biotech Limited

FY 2025-26 filings available

Fermenta Biotech Limited reported revenue of ₹525.43 Cr (up 11.9% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹525 Cr
+11.9% YoY
EBITDA
₹101 Cr
-8.6% YoY
Profit After Tax
₹62.91 Cr
-22.4% YoY
Net Worth
₹406 Cr
+12.0% YoY
Total Assets
₹541 Cr
+8.7% YoY
Total Debt
₹113 Cr
-1.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue525469336350399377292
Revenue growth+11.9%+39.9%-4.1%-12.2%+5.6%+29.3%-
EBITDA10111120.47(10.28)62.3682.6966.19
EBITDA margin+19.2%+23.5%+6.1%-2.9%+15.7%+21.9%+22.7%
Profit before tax95.8683.22(9.87)(51.30)26.9651.6343.42
Net profit62.9181.06(16.63)(23.95)15.4745.6457.78
Net profit margin+12.0%+17.3%-5.0%-6.8%+3.9%+12.1%+19.8%
EPS (₹)25.0326.35(7.99)(17.70)5.3515.7720.63
Balance sheet
Total assets541498465562622598539
Net worth406363289315372361309
Total debt113115139220239232224
Cash & bank41.3471.7059.8358.3333.6144.5333.11
Net working capital282219159175229220209
Cash flow
Cash from operations92.8340.9010511643.4462.6034.46
Cash from investing(43.00)(0.16)(15.50)(55.36)(26.04)(40.94)(43.66)
Cash from financing(42.29)(50.87)(90.85)(41.38)(21.58)(1.14)(47.45)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue12212213713013614015695.03
Revenue growth (YoY)-10.6%-13.1%-12.2%+37.0%+74.4%---
Other income4.3714.143.125.438.773.892.232.88
EBITDA18.0520.0022.7726.6328.2336.9553.2718.78
EBITDA margin+14.8%+16.5%+16.6%+20.5%+20.7%+26.4%+34.0%+19.8%
Depreciation5.205.115.375.415.815.866.086.15
Interest2.542.823.032.583.112.994.083.69
Profit before tax14.6826.2117.4924.0728.0831.9945.3411.82
Tax5.167.615.466.066.48(1.34)7.450.70
Net profit9.5218.6012.0318.0121.6033.3337.8911.12
EPS (₹)3.346.614.346.157.4711.7912.713.94
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue450431307329388373299
Revenue growth+4.6%+40.2%-6.6%-15.2%+4.1%+24.6%-
EBITDA91.6710128.33(20.61)76.8294.7370.45
EBITDA margin+20.4%+23.4%+9.2%-6.3%+19.8%+25.4%+23.5%
Profit before tax89.2274.42(4.62)(57.99)42.5763.2247.55
Net profit55.2171.71(7.75)3.0730.2652.0961.77
Net profit margin+12.3%+16.7%-2.5%+0.9%+7.8%+14.0%+20.6%
EPS (₹)22.4223.18(6.49)(19.75)10.4818.0122.07
Balance sheet
Total assets563519494585649610544
Net worth423380314336396370313
Total debt113115139219241234226
Cash & bank18.0261.9556.6455.1130.7541.3032.37
Net working capital270218168172251235216
Cash flow
Cash from operations82.6333.8310512450.4162.9629.83
Cash from investing(46.00)0.41(15.15)(63.47)(32.46)(43.61)(39.19)
Cash from financing(42.15)(50.91)(90.86)(41.25)(21.76)(1.32)(47.63)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11211011410711912214689.54
Revenue growth (YoY)-6.0%-10.0%-21.9%+19.6%+63.7%---
Other income4.9015.173.435.538.843.882.222.95
Total expenses88.8688.0492.8884.1596.4989.3696.1274.05
EBITDA22.9821.8421.3622.9722.5332.6850.1315.49
EBITDA margin+20.5%+19.9%+18.7%+21.4%+18.9%+26.8%+34.3%+17.3%
Depreciation5.195.085.175.135.555.605.825.89
Interest2.542.773.032.593.112.994.093.69
Profit before tax20.1529.1616.5920.7822.7127.9742.448.86
Tax5.167.584.836.066.48(1.34)7.450.70

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 23 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue12212213713013614015695.03
Revenue growth (YoY)-10.6%-13.1%-12.2%+37.0%+74.4%---
Other income4.3714.143.125.438.773.892.232.88
EBITDA18.0520.0022.7726.6328.2336.9553.2718.78
EBITDA margin+14.8%+16.5%+16.6%+20.5%+20.7%+26.4%+34.0%+19.8%
Depreciation5.205.115.375.415.815.866.086.15
Interest2.542.823.032.583.112.994.083.69
Profit before tax14.6826.2117.4924.0728.0831.9945.3411.82
Tax5.167.615.466.066.48(1.34)7.450.70
Net profit9.5218.6012.0318.0121.6033.3337.8911.12
EPS (₹)3.346.614.346.157.4711.7912.713.94
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue525469336350399377292
Revenue growth+11.9%+39.9%-4.1%-12.2%+5.6%+29.3%-
Other income29.2611.8211.818.608.148.2512.32
Total expenses424359315360336295226
Employee cost82.5965.1058.5558.0062.9758.2250.03
EBITDA10111120.47(10.28)62.3682.6966.19
EBITDA margin+19.2%+23.5%+6.1%-2.9%+15.7%+21.9%+22.7%
Depreciation21.7024.2224.7228.2525.5620.3115.00
Interest12.6614.8917.4321.3717.9819.0020.09
Profit before tax95.8683.22(9.87)(51.30)26.9651.6343.42
Tax25.616.8014.141.8311.899.10(16.10)
Net profit62.9181.06(16.63)(23.95)15.4745.6457.78
Net profit margin+12.0%+17.3%-5.0%-6.8%+3.9%+12.1%+19.8%
EPS (₹)25.0326.35(7.99)(17.70)5.3515.7720.63
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14.3414.5814.4414.4314.4214.4214.42
Reserves & surplus392348274301358346295
Shareholders' funds (net worth)406363289315372361309
Minority interest(5.67)(4.16)(3.70)(2.75)(0.68)(0.30)0.01
Secured loans109109132217236229220
Unsecured loans4.445.546.502.683.042.863.69
Total debt113115139220239232224
Total liabilities541498465562622598539
Assets
Gross block386372402377393331248
Net block220227269267299263200
Capital work in progress13.1115.911.6245.0234.5756.9170.77
Investments0.420.490.433.150.290.250.26
Inventories15312487.38130159162129
Sundry debtors11295.2369.8341.6587.0968.0169.77
Cash & bank balances41.3471.7059.8358.3333.6144.5333.11
Loans & advances82.5544.6624.7120.1333.8534.8052.54
Total current assets388335242250314310284
Total current liabilities10711682.5774.7784.5989.2975.05
Net working capital282219159175229220209
Total assets541498465562622598539
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.6316.7517.75(1.61)2.29(18.22)38.42
Net cash from operating activities92.8340.9010511643.4462.6034.46
Net cash from investing activities(43.00)(0.16)(15.50)(55.36)(26.04)(40.94)(43.66)
Net cash from financing activities(42.29)(50.87)(90.85)(41.38)(21.58)(1.14)(47.45)
Net change in cash7.55(10.12)(1.00)19.37(4.17)20.52(56.65)
Closing cash41.3471.7059.8358.3333.6144.5333.11
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.9%+39.9%-4.1%-12.2%+5.6%+29.3%-
EBITDA growth-8.6%+439.9%+299.1%-116.5%-24.6%+24.9%-
PBT growth+15.2%+9998.0%+80.8%--47.8%+18.9%-66.3%
Net income growth-22.4%+587.4%+30.6%-254.8%-66.1%-21.0%-
Revenue CAGR (3Y)+14.5%+5.6%-3.8%+6.3%-0.4%+7.7%+21.2%
EBITDA CAGR (3Y)-+21.0%-37.2%--25.3%-3.9%+76.9%
Profitability & leverage
Net income margin+13.4%+16.3%-7.2%-15.2%+3.8%+11.3%+20.4%
Return on capital employed+20.7%+20.2%+3.0%-0.2%+7.4%+12.4%+12.6%
Return on net worth+18.3%+23.5%-5.8%-7.6%+4.1%+12.7%+21.3%
Debt / equity0.300.390.590.670.640.680.77
Long-term debt / equity0.040.090.180.270.310.320.43
Interest cover15.9717.26-410.12-55.4648.8630.4639.25
Efficiency & per share
Fixed asset turnover1.391.210.860.911.101.301.27
Inventory turnover3.804.453.092.422.482.592.71
Debtors turnover5.085.696.025.445.145.484.33
EPS (₹)25.0326.35(7.99)(17.70)5.3515.7720.63
Dividend per share (₹)3.752.501.251.251.252.505.00
Book value per share (₹)141.68124.33100.04109.27129.00125.00107.27
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11211011410711912214689.54
Revenue growth (YoY)-6.0%-10.0%-21.9%+19.6%+63.7%---
Other income4.9015.173.435.538.843.882.222.95
Total expenses88.8688.0492.8884.1596.4989.3696.1274.05
EBITDA22.9821.8421.3622.9722.5332.6850.1315.49
EBITDA margin+20.5%+19.9%+18.7%+21.4%+18.9%+26.8%+34.3%+17.3%
Depreciation5.195.085.175.135.555.605.825.89
Interest2.542.773.032.593.112.994.093.69
Profit before tax20.1529.1616.5920.7822.7127.9742.448.86
Tax5.167.584.836.066.48(1.34)7.450.70
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue450431307329388373299
Revenue growth+4.6%+40.2%-6.6%-15.2%+4.1%+24.6%-
Other income30.8711.688.158.467.536.6212.31
Total expenses359330279350311278229
Employee cost74.1460.1053.9353.8159.3657.5050.03
EBITDA91.6710128.33(20.61)76.8294.7370.45
EBITDA margin+20.4%+23.4%+9.2%-6.3%+19.8%+25.4%+23.5%
Depreciation20.9423.1723.7024.4923.6719.0314.94
Interest12.3814.8417.4021.3518.1119.1020.27
Profit before tax89.2274.42(4.62)(57.99)42.5763.2247.55
Tax24.966.8014.14(0.97)12.3311.26(16.12)
Net profit55.2171.71(7.75)3.0730.2652.0961.77
Net profit margin+12.3%+16.7%-2.5%+0.9%+7.8%+14.0%+20.6%
EPS (₹)22.4223.18(6.49)(19.75)10.4818.0122.07
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital14.3414.5814.4414.4314.4214.4214.42
Reserves & surplus408365300322382356298
Shareholders' funds (net worth)423380314336396370313
Secured loans109109132217236229220
Unsecured loans4.445.546.502.684.794.655.56
Total debt113115139219241234226
Total liabilities563519494585649610544
Assets
Gross block376362384358377315244
Net block220226267257287250197
Capital work in progress13.1115.911.6245.0234.5756.9170.77
Investments11.623.693.6315.3512.9912.951.11
Inventories13194.4878.61110130133114
Sundry debtors13712077.1367.4111896.1277.44
Cash & bank balances18.0261.9556.6455.1130.7541.3032.37
Loans & advances73.6243.8725.8518.2737.1037.7559.10
Total current assets360321238251315308282
Total current liabilities89.2210370.2078.6764.1272.8065.96
Net working capital270218168172251235216
Total assets563519494585649610544
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash(3.12)13.5614.54(4.49)(0.94)(18.96)38.02
Net cash from operating activities82.6333.8310512450.4162.9629.83
Net cash from investing activities(46.00)0.41(15.15)(63.47)(32.46)(43.61)(39.19)
Net cash from financing activities(42.15)(50.91)(90.86)(41.25)(21.76)(1.32)(47.63)
Net change in cash(5.52)(16.67)(0.98)19.03(3.81)18.03(56.99)
Closing cash18.0261.9556.6455.1130.7541.3032.37
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+4.6%+40.2%-6.6%-15.2%+4.1%+24.6%-
EBITDA growth-9.0%+255.6%+237.5%-126.8%-18.9%+34.5%-
PBT growth+19.9%+9998.0%+92.0%--32.7%+33.0%-60.7%
Net income growth-23.0%+1025.3%-352.4%-89.9%-41.9%-15.7%-
Revenue CAGR (3Y)+11.0%+3.5%-6.3%+3.2%-1.3%+210.0%+278.5%
EBITDA CAGR (3Y)-+9.5%-33.1%--18.5%--
Profitability & leverage
Net income margin+14.3%+15.7%-6.1%-17.3%+7.8%+13.9%+21.3%
Return on capital employed+18.8%+17.6%+4.1%+3.8%+9.7%+14.3%+13.4%
Return on net worth+16.0%+19.5%-2.4%+0.8%+7.9%+15.2%+22.7%
Debt / equity0.280.370.550.630.620.670.77
Long-term debt / equity0.040.080.160.260.300.320.43
Interest cover17.5019.13375.81-47.3434.0725.2336.52
Efficiency & per share
Fixed asset turnover1.221.160.830.891.121.331.33
Inventory turnover4.004.973.262.752.963.032.99
Debtors turnover3.504.364.253.553.634.304.20
EPS (₹)22.4223.18(6.49)(19.75)10.4818.0122.07
Dividend per share (₹)3.752.501.251.251.252.505.00
Book value per share (₹)147.47130.26108.83116.45137.26128.42108.36

To see the full year-wise statements and ratios of Fermenta Biotech Limited, buy the company report.

Board of directors of Fermenta Biotech Limited

Fermenta Biotech has 9 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajashri Santosh Kumar Ojha
Also directs: Instapill Private Limited, Raaj Gprac Private Limited
Director01 Apr 20206 Years 6 MonthsCurrent
Anupama Datla Desai
Also directs: Dupen Laboratories Private Limited, Lacto-Cosmetics (Vapi) Private Limited
Whole-Time Director27 Sep 20197 Years 0 MonthsCurrent
Satish Varma Azad NadimpallyWhole-Time Director01 Jul 200323 Years 3 MonthsCurrent
Prashant Prabhakar Nagre
Also directs: Fermenta Environment Solutions Private Limited
Managing Director06 May 20215 Years 5 MonthsCurrent
Krishna Vasantkumar DatlaWhole-Time Director09 May 201016 Years 5 MonthsCurrent
Pramod Kasat
Also directs: Advanced Enzyme Technologies Limited, Sai Silks (Kalamandir) Limited, Natural Capsules Limited and 5 more
Director30 May 20224 Years 4 MonthsCurrent
Showing 6 of 9 current directors. View all directors

Auditor

Fermenta Biotech Limited is audited by S R B C & CO LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
S R B C & CO LLPFY 2023324982E/E300003

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 64.10%, foreign institutional investors hold 0.10%, domestic institutional investors hold 0.10% and retail and other public shareholders hold 35.70%.

Promoters: 64.10%DII (Domestic Institutional): 0.10%FII (Foreign Institutional): 0.10%Retail & Others: 35.70%
Sep 2026
QUARTER
64.10% Promoters
0.10% DII (Domestic Institutional)
0.10% FII (Foreign Institutional)
35.70% Retail & Others
Promoter holding - history
Now 64.10% · Sep 2026High 64.10% · Dec 2025Low 64.10% · Dec 2025
63%63.8%64.5%65.3%66%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 64.10%Mar 2026: 64.10%Jun 2026: 64.10%Sep 2026: 64.10%64.10%64.10%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters64.10%64.10%64.10%64.10%
Public35.90%35.90%35.90%35.90%

Charges & borrowings

Open charges
₹294.16 Cr
Satisfied charges
₹351.46 Cr
Breakdown by lending institutions
Others₹190.29 Cr
Hdfc Bank Limited₹65.71 Cr
Yes Bank Limited₹30.16 Cr
Union Bank of India Ghodbunder Road Branch,₹6.00 Cr
Union Bank of India₹2.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 May 2023100730973Yes Bank Limited₹16 LakhOpen
30 Sep 2022100620404Others₹68.43 LakhOpen
21 Sep 2022100611954Others₹66 LakhOpen
07 Sep 2022100608504Others₹27 LakhOpen
24 Aug 2022100608266Others₹17.92 LakhOpen

To see the full charge records of Fermenta Biotech Limited, buy the company report.

Total charge records: 72 View all charges

MSME payment delays

Fermenta Biotech Limited has 13 MSME Form 1 returns on record between 2020 and 2024, listing 873 overdue payments to 148 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 148)

SupplierAmount dueDue sinceReported on
Supra Sciences Private Limited
an individual supplier
Vrata Tech Solutions Private Limited
an individual supplier
an individual supplier

To see the full MSME payment records of Fermenta Biotech Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

Fermenta Biotech has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

2
Subsidiary companies
1
Associated companies
Key subsidiaries
Company NameCINShares held
G I Biotech Private LimitedU24230MH2004PTC148220
Aegean Properties LimitedU45200MH1995PLC084766

To see the full group structure of Fermenta Biotech Limited, buy the company report.

Employees & EPFO

Fermenta Biotech Limited has a workforce of 327 employees on its EPFO records as of Apr 09, 2024, across 4 active EPFO establishments.

Employee count
327
Active EPFO establishments
4
Employee growth
-5.76%

GST

Fermenta Biotech has 14 GST registrations: 13 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
14
Active
13
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACD0525E1Z9MaharashtraActive01 Jul 2017
27AAACD0525E2Z8MaharashtraActive02 Dec 2019
27AAACD0525E4Z6MaharashtraActive07 Oct 2024
02AAACD0525E1ZLHimachal PradeshActive10 Dec 2019

To see the full GST registrations and return filing status of Fermenta Biotech Limited, buy the company report.

Recent activity

Fermenta Biotech Limited has 29 board changes on record since 2001: 20 appointments and 9 cessations. The latest: Ramanand Mundkur was appointed as Director on 14 Nov 2024.

Charges
A charge registered on 31 Dec 2020 via Charge ID 100416532 with Others was fully satisfied on 26 May 2026.
Charges
A charge registered on 08 Apr 2021 via Charge ID 100435570 with Others was fully satisfied on 22 May 2026.
Charges
A charge registered on 08 Apr 2021 via Charge ID 100435576 with Others was fully satisfied on 07 May 2026.
Filing
Fermenta Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai Ii.
Charges
A charge registered on 02 Jul 2025 via Charge ID 101128371 with Hdfc Bank Limited was fully satisfied on 20 Nov 2025.
Charges
A charge registered on 26 Jun 2025 via Charge ID 101117517 with Hdfc Bank Limited was fully satisfied on 16 Oct 2025.
AGM
Fermenta Biotech Limited last Annual general meeting of members was held on 12 Aug 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 30.00 Cr registered on 10 Aug 2020 with Charge ID 100357520 was modified on 29 Jul 2025.
Charges
A charge registered on 29 Dec 2021 via Charge ID 100526193 with Others was fully satisfied on 10 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101128371 was registered on 02 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 101117517 was registered on 26 Jun 2025.
Charges
A charge registered on 29 Nov 2017 via Charge ID 100137792 with Others was fully satisfied on 10 Dec 2024.

160 earlier events are in the company report.

News

Frequently asked questions

Fermenta Biotech is an active public limited company based in Thane, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 01 May 1951 (75+ years old) and is registered under CIN L99999MH1951PLC008485. Listed on BSE: 506414 and NSE: FERMENTA.

Fermenta Biotech reported revenue of ₹525.43 Cr for FY 2025-26 (up 11.9% YoY) based on consolidated financials.

Fermenta Biotech has 9 current directors:

The latest financial statements of Fermenta Biotech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 12 August 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Fermenta Biotech is 27AAACD0525E1Z9, registered in Maharashtra. The company has 14 GST registrations in all, of which 13 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACD0525E2Z8 (Maharashtra), 27AAACD0525E4Z6 (Maharashtra), 02AAACD0525E1ZL (Himachal Pradesh).

The CIN (Corporate Identification Number) of Fermenta Biotech is L99999MH1951PLC008485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Fermenta Biotech is a listed company as per MCA records. Its shares are listed on both BSE (code: 506414) and NSE (symbol: FERMENTA).

Fermenta Biotech has 28 court cases on record: 15 filed by the company and 13 filed against it. 2 are pending. Most are in the district courts.

Fermenta Biotech was incorporated on 01 May 1951, making it 75+ years old. It is registered with the Registrar of Companies, Mumbai.

Ramanand Mundkur was appointed as Director on 14 Nov 2024. Varadvinayak Vijay Khambete was appointed as Company Secretary on 30 Jul 2024. Srikant Nath Sharma ceased to be Company Secretary on 23 Jul 2024. Fermenta Biotech has 29 board changes on record in total.

Fermenta Biotech has 13 MSME Form 1 returns on record between 2020 and 2024, listing 873 overdue payments to 148 micro and small suppliers. The latest return was filed on 01 May 2024.